Announcement on Expected Loss in Performance for 2025
Filed with SSE · · 2 pages · Chinese
Youcare Pharmaceutical Group Co. Ltd. on 6ix
Earlier from Youcare Pharmaceutical
- Notice on Convening the 1st Extraordinary General Meeting in 2026
- Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025
- Announcement on Voluntary Disclosure of Subsidiary’s YKYY032 Injection Obtaining Clinical Trial Approval from the National Medical Products Administration and FDA
- Announcement on Voluntary Disclosure of Subsidiary’s YKYY031 Injection Obtaining Clinical Trial Approval from the National Medical Products Administration
- Announcement on Appointment of an Additional Director and Adjustment of Members of Special Committees of the Board of Directors
Later from Youcare Pharmaceutical
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Announcement on Resignation of Director and Senior Management Member and Election of Employee Director
- Indicative Announcement on Judicial Auction of Some Shares Held by Controlling Shareholders
- Announcement on Preliminary Earnings Estimate for 2025
- Announcement on the Failure of Judicial Auction of Partial Shares Held by Controlling Shareholders
Follow Youcare Pharmaceutical into a list and get an email when it puts out news.
Follow Youcare Pharmaceutical